EIF's Lee Jeans Translational Breast Cancer Research Program supports research to design and develop new and innovative non-toxic cancer therapies targeted at several different types of breast cancer that have traditionally been difficult to treat. Researchers have already been successful with this approach for some forms of breast cancer, demonstrating that the principle of targeted therapies is valid and viable. The goal now is to develop more and better targeted treatments for the broader spectrum of breast cancers, including those that develop resistance to the best targeted therapies currently available.
The basic premise behind translational research is really quite simple: once the molecular malfunction
causing the cancer cells to grow and multiply is identified and understood, that knowledge can be used, or
translated into targeted therapies that attack the cancer and correct the malfunction without destroying healthy cells. This represents a quantum leap forward in the advancement of cancer research, and a source of great hope for cancer patients everywhere.
This exciting new research is being conducted at six of the nation’s leading medical institutions which have been named EIF’s Lee Translational Laboratories, and receive funding through EIF’s Women’s Cancer Programs from Lee National Denim Day.
Sidney Kimmel Comprehensive Cancer Center
Martin D. Abeloff, M.D.
Nancy E. Davidson, M.D.
Vanderbilt-Ingram Breast Cancer Program
Carlos L. Ateaga, M.D.
Harvard Medical School
Joan S. Brugge, Ph.D.
Pritzker School of Medicine
Funmi I. Olopade, M.D., FACP
Baylor College of Medicine
C. Kent Osborne, M.D.
Jonsson Comprehensive Cancer Center
Dennis J. Slamon, M.D., Ph.D.
Through a $1 million donation to EIF's Women's Cancer Programs, the Callaway Golf Foundation Women's Cancer Initiative has been established at four outstanding cancer institutions. The institutions selected for their groundbreaking work in ovarian cancer research and treatment include:
Cedars-Sinai Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute
The University of Texas M.D. Anderson Cancer Center
Memorial Sloan-Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
